174 related articles for article (PubMed ID: 18452309)
1. Abl N-terminal cap stabilization of SH3 domain dynamics.
Chen S; Dumitrescu TP; Smithgall TE; Engen JR
Biochemistry; 2008 May; 47(21):5795-803. PubMed ID: 18452309
[TBL] [Abstract][Full Text] [Related]
2. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
Chen S; Brier S; Smithgall TE; Engen JR
Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
Chen S; O'Reilly LP; Smithgall TE; Engen JR
J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
[TBL] [Abstract][Full Text] [Related]
4. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
[TBL] [Abstract][Full Text] [Related]
6. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
8. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
11. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
12. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
13. c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution.
Badger J; Grover P; Shi H; Panjarian SB; Engen JR; Smithgall TE; Makowski L
Biochemistry; 2016 Jun; 55(23):3251-60. PubMed ID: 27166638
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism.
Nam HJ; Haser WG; Roberts TM; Frederick CA
Structure; 1996 Sep; 4(9):1105-14. PubMed ID: 8805596
[TBL] [Abstract][Full Text] [Related]
15. Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin.
Gifford SM; Liu W; Mader CC; Halo TL; Machida K; Boggon TJ; Koleske AJ
J Biol Chem; 2014 Jul; 289(28):19704-13. PubMed ID: 24891505
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer BJ; Baltimore D
Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
[TBL] [Abstract][Full Text] [Related]
17. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
[TBL] [Abstract][Full Text] [Related]
20. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
